Stock & Company Details
Adaptive Biotechnologies Corp $ADPT
Price:
N/A
N/A
160M
$4.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-63.96
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
ADPT technical indicators
Latest Adaptive Biotechnologies Corp (ADPT) indicator readings as of 2026-10-09.
ADPT's 14-day RSI is 47.4, in neutral territory. At $26.49 it is trading 40.0% above its 200-day moving average of $18.92, and above its 50-day average of $26.02. Price sits in the middle of its Bollinger Bands ($25.28 to $30.38). ADX reads 18.6, indicating a range-bound market rather than a trend.
Overview
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies believes the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Its proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have three commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.
Finance Bot
Ask your questions
Start by typing a question below.
